There have been 33 complaints closed in the last three years
The medication's effect on appetite is secondary rather than primary, making it less potent for weight loss than medications designed specifically to target appetite centers in the brain
Both medications share the same rarer but more serious risks listed for the GLP-1 class, including pancreatitis and gallbladder problems, so any severe or persistent stomach pain should be checked by a doctor
Semaglutide belongs to a group called GLP-1 receptor agonists, also known as incretin mimetics
Researchers who have encountered questions about timing, metabolic interactions, or the persistence of peptide effects in research models may find useful parallel context in our article on how long peptide-related effects last in GLP-1 receptor agonist research
Understanding common side effects 1 The most common adverse reactions, reported in 5% of patients treated with RYBELSUS are: nausea abdominal pain diarrhea decreased appetite vomiting constipation In the pool of placebo-controlled trials, the majority of reports of nausea, vomiting, and/or diarrhea occurred during dose escalation
